942922-07-8 Usage
General Description
2-(4-Methylpiperazin-1-yl)pyrimidine-5-boronic acid pinacol ester is a chemical compound with potential applications in medicinal and pharmaceutical research. It is a boronic acid ester derivative, which is a widely used class of compounds in the field of drug discovery and development. This particular compound contains a pyrimidine ring with a boronic acid functional group and a pinacol ester moiety, making it suitable for use in Suzuki-Miyaura cross-coupling reactions and other synthetic methodologies. The presence of the 4-methylpiperazine group also suggests potential interactions with biological targets such as receptors and enzymes, making it a valuable tool for the design and synthesis of biologically active molecules. Overall, 2-(4-Methylpiperazin-1-yl)pyrimidine-5-boronic acid pinacol ester is a versatile and valuable chemical building block for medicinal chemistry and drug discovery research.
Check Digit Verification of cas no
The CAS Registry Mumber 942922-07-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,2,9,2 and 2 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 942922-07:
(8*9)+(7*4)+(6*2)+(5*9)+(4*2)+(3*2)+(2*0)+(1*7)=178
178 % 10 = 8
So 942922-07-8 is a valid CAS Registry Number.
942922-07-8Relevant articles and documents
1,5,7-TRISUBSTITUTED ISOQUINOLINE DERIVATIVES, PREPARATION THEREOF, AND USE THEREOF IN MEDICINES
-
Paragraph 0230; 0232; 0234, (2020/08/30)
The present disclosure relates to 1,5,7-trisubstituted isoquinoline derivatives, their preparation and pharmaceutical use. In particular, the present disclosure discloses a compound of formula (I) or a pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof, and a preparation method and use thereof. The definitions of the groups in the formula can be found in the specification and claims.
AZAINDOLE INHIBITORS OF AURORA KINASES
-
Page/Page column 105, (2008/06/13)
The present invention relates to a compound represented by Formula (I): and pharmaceutically acceptable salts. Compounds of the present invention inhibit Aurora kinase, making them especially suitable for the treatment of a number of diseases, including s